Hoth Therapeutics expands at-the-market offering by $5 million
Hoth Therapeutics , Inc. (NASDAQ:HOTH), a biopharmaceutical company, announced today that it has increased the maximum aggregate offering price of its common stock by $5 million under its existing At ...
Denali Therapeutics Announces Primary Analysis and Long-Term Follow-Up of Phase 1/2 Study in Hunter Syndrome (MPS II) with Tividenofusp Alfa
Long-term data demonstrate that robust reductions and normalization in key biomarkers from baseline were maintained over time with continued ...
Psychology Today4d
Therapy Wins You Might Be Missing
Progress in therapy doesn’t mean always feeling good. Sometimes, it means finally feeling everything. Experiencing pain in ...